A novel prolyl endopeptidase inhibitor, JTP-4819, with potential for treating Alzheimer's disease
- 1 February 1997
- journal article
- Published by Elsevier in Behavioural Brain Research
- Vol. 83 (1-2) , 147-151
- https://doi.org/10.1016/s0166-4328(97)86059-7
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with alzheimer's diseaseCellular and Molecular Life Sciences, 1990
- Trophic Effect of Thyrotropin-Releasing Hormone in Murine Ventral Horn Neuronal CulturesAnnals of the New York Academy of Sciences, 1989
- Differential Alteration of Various Cholinergic Markers in Cortical and Subcortical Regions of Human Brain in Alzheimer's DiseaseJournal of Neurochemistry, 1988
- Substance P‐like immunoreactivity is reduced in Alzheimer's disease cerebral cortexNeurology, 1987
- The importance of vasopressin in memoryTrends in Neurosciences, 1984
- Central target for the behavioural effects of vasopressin neuropeptidesNature, 1984
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Cortical Substance P‐Like Immunoreactivity in Cases of Alzheimer's Disease and Senile Dementia of the Alzheimer TypeJournal of Neurochemistry, 1982
- Subcellular Distribution of Prolyl Endopeptidase and Cation‐Sensitive Neutral Endopeptidase in Rabbit BrainJournal of Neurochemistry, 1982